Esperela, May Jae G.

HRN: 29-36-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
CEFUROXIME 750MG (VIAL)
07/23/2026
07/23/2026
IV
750
Q8
SP ORIF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: